Piramal Pharma Limited

Piramal Pharma Limited - Enterprise Valueverified

PPLPHARMA.NS

Price:

$211.35

Market Cap:

$280.04B

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, dig...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-10-19

Stock Exchange

NSE

Ticker

PPLPHARMA.NS

The Enterprise Value as of September 2026 (TTM) for Piramal Pharma Limited (PPLPHARMA.NS) is 280.04B

According to Piramal Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 280.04B. This represents a change of 16.41% compared to the average of 240.56B of the last 4 quarters.

Piramal Pharma Limited (PPLPHARMA.NS) Historical Enterprise Value (quarterly & annually)

How has PPLPHARMA.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Piramal Pharma Limited over the last ten years is 234.41B. The current 280.04B Enterprise Value has changed 11.85% with respect to the historical average. Over the past ten years (40 quarters), PPLPHARMA.NS's Enterprise Value was at its highest in in the September 2024 quarter at 348.20B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

234.41B

Median

225.75B

Minimum

135.48B

Maximum

345.79B

Piramal Pharma Limited (PPLPHARMA.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Piramal Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 65.55%

Maximum Annual Enterprise Value = 345.79B

Minimum Annual Increase = -48.84%

Minimum Annual Enterprise Value = 135.48B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2026225.42B-34.81%
2025345.79B65.55%
2024208.88B54.17%
2023135.48B-48.84%
2022264.81B17.13%

Piramal Pharma Limited (PPLPHARMA.NS) Average Enterprise Value

How has PPLPHARMA.NS Enterprise Value performed in the past?

The current Enterprise Value of Piramal Pharma Limited (PPLPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

260.03B

5-year avg

236.08B

10-year avg

234.41B

Piramal Pharma Limited (PPLPHARMA.NS) Enterprise Value vs. Peers

How is PPLPHARMA.NS’s Enterprise Value compared to its peers?

Piramal Pharma Limited’s Enterprise Value is greater than Syngene International Limited (157.24B), greater than Syngene International Limited (157.24B), greater than Piramal Enterprises Limited (0), less than J. B. Chemicals & Pharmaceuticals Limited (386.86B), less than J. B. Chemicals & Pharmaceuticals Limited (386.86B), less than Dr. Lal PathLabs Limited (318.76B), less than Dr. Lal PathLabs Limited (318.76B), less than Inventurus Knowledge Solutions Ltd. (295.62B), less than Inventurus Knowledge Solutions Ltd. (295.62B), greater than AstraZeneca Pharma India Limited (169.11B),

Build a custom stock screener for Piramal Pharma Limited (PPLPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Piramal Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Piramal Pharma Limited (PPLPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Piramal Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Piramal Pharma Limited's Enterprise Value?

What is the highest Enterprise Value for Piramal Pharma Limited (PPLPHARMA.NS)?

What is the 3-year average Enterprise Value for Piramal Pharma Limited (PPLPHARMA.NS)?

What is the 5-year average Enterprise Value for Piramal Pharma Limited (PPLPHARMA.NS)?

How does the current Enterprise Value for Piramal Pharma Limited (PPLPHARMA.NS) compare to its historical average?